Last update 13 Nov 2025

GW906

Overview

Basic Info

Drug Type
siRNA
Synonyms
GW906, SAL0132
Target
AGT
Action
inhibitors
Mechanism
AGT inhibitors(Angiotensinogen inhibitors)
Therapeutic Areas
Cardiovascular Diseases
Active Indication
Essential Hypertension
Inactive Indication-
Originator Organization
Chengdu Guowei Biopharmaceutical Co. Ltd.Chengdu Guowei Biopharmaceutical Co. Ltd.
Active Organization
Chengdu Tiantaishan Pharmaceutical Co., Ltd.Chengdu Tiantaishan Pharmaceutical Co., Ltd.Chengdu Guowei Biopharmaceutical Co. Ltd.Chengdu Guowei Biopharmaceutical Co. Ltd.
Inactive Organization-
License Organization
Shenzhen Salubris Pharmaceuticals Co., Ltd.Shenzhen Salubris Pharmaceuticals Co., Ltd.Chengdu Guowei Biopharmaceutical Co. Ltd.Chengdu Guowei Biopharmaceutical Co. Ltd.
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Boost your research with our RNA technology data.
login
or
view full example data
Boost your research with our RNA technology data.

Related

2
Clinical Trials associated with GW906
CTR20251035
/ RecruitingPhase 1
GW906注射液在中国健康受试者和轻度高血压受试者中的安全性、耐受性、药代动力学和药效学特征的I期临床研究
[Translation] A Phase I clinical study of the safety, tolerability, pharmacokinetics and pharmacodynamics of GW906 injection in Chinese healthy subjects and subjects with mild hypertension
CTR20254537
/ Not yet recruitingPhase 2
在原发性高血压患者中，评价GW906注射液（SAL0132）有效性和安全性的多中心、随机、双盲、安慰剂对照的Ⅱ期临床研究
[Translation] A multicenter, randomized, double-blind, placebo-controlled phase II clinical trial evaluating the efficacy and safety of GW906 injection (SAL0132) in patients with essential hypertension.
100 Clinical Results associated with GW906
Login to view more data
100 Translational Medicine associated with GW906
Login to view more data
100 Patents (Medical) associated with GW906
Login to view more data
100 Deals associated with GW906
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Essential HypertensionPhase 2
China
Chengdu Tiantaishan Pharmaceutical Co., Ltd.Chengdu Tiantaishan Pharmaceutical Co., Ltd.
13 Nov 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free